Riggelsen Care ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  3.6% 3.6% 3.6% 3.6% 3.6%  
Bankruptcy risk  16.8% 14.2% 16.8% 14.5% 12.6%  
Credit score (0-100)  11 15 9 14 17  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  -53.9 0.0 0.0 0.0 0.0  
EBITDA  -56.7 -58.5 -109 -52.6 30.0  
EBIT  -56.7 -58.5 -109 -52.6 30.0  
Pre-tax profit (PTP)  -59.0 -71.2 -121.5 -76.8 5.2  
Net earnings  -59.0 -71.2 -121.5 -76.8 5.2  
Pre-tax profit without non-rec. items  -59.0 -71.2 -121 -76.8 27.3  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -29.4 -89.1 -211 -287 -282  
Interest-bearing liabilities  0.0 12.4 11.7 21.7 163  
Balance sheet total (assets)  202 163 32.9 326 221  

Net Debt  -92.5 -49.3 -17.1 -109 59.8  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -53.9 0.0 0.0 0.0 0.0  
Gross profit growth  -218.1% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  202 163 33 326 221  
Balance sheet change%  580.1% -19.3% -79.8% 889.1% -32.3%  
Added value  -56.7 -58.5 -109.3 -52.6 30.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  105.2% 0.0% 0.0% 0.0% 0.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -43.6% -24.2% -44.1% -12.3% 5.4%  
ROI %  -43.5% -47.8% -908.7% -314.7% 32.4%  
ROE %  -51.0% -39.0% -124.0% -42.8% 1.9%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -12.6% -35.3% -86.5% -46.9% -56.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  163.1% 84.4% 15.7% 207.0% 199.4%  
Gearing %  -0.1% -13.9% -5.5% -7.6% -57.9%  
Net interest  0 0 0 0 0  
Financing costs %  11,426.3% 205.7% 101.9% 145.2% 2.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  -237.2 3.3 2.6 -0.7 0.6  
Current Ratio  -246.4 8.1 2.9 2.8 1.3  
Cash and cash equivalent  92.6 61.7 28.8 130.6 103.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  202.6 142.9 21.4 92.9 47.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0